ResMed, Inc.

RMD

US7611521078

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 04:00:02 2024-07-02 pm EDT			5-day change	1st Jan Change
189.4 ^USD	+1.29%		+3.00%	+10.07%

Jun. 25	Oppenheimer Downgrades ResMed to Market Perform From Outperform	MT
Jun. 24	Shares of ResMed, Inspire Medical Down After Eli Lilly Provides Sleep Apnea Study Update	DJ

ResMed Inc. Announces Ordinary Distribution for the Quarter Ended December 31, 2021, Payable on March 17, 2022

January 27, 2022 at 04:32 pm EST

ResMed Inc. announced ordinary distribution of USD 0.04200000 for the quarter ended December 31, 2021. Record date is February 10, 2022. Ex-date is February 9, 2022.

The dividend will be payable on March 17, 2022.

Latest news about ResMed, Inc.

Oppenheimer Downgrades ResMed to Market Perform From Outperform	Jun. 25	MT
Shares of ResMed, Inspire Medical Down After Eli Lilly Provides Sleep Apnea Study Update	Jun. 24	DJ
Global markets live: Novo Nordisk, Apple, UPS, Eli Lilly, Qualcomm...	Jun. 24
Top Premarket Decliners	Jun. 24	MT
Resmed Insider Sold Shares Worth $3,107,739, According to a Recent SEC Filing	Jun. 11	MT
ResMed Says Research Shows Effectiveness of Positive Airway Pressure Therapy For Sleep Apnea	May. 23	MT
Transcript : ResMed Inc. Presents at 2024 RBC Capital Markets Global Healthcare Conference, May-14-2024 04:05 PM	May. 14
Resmed Insider Sold Shares Worth $2,747,810, According to a Recent SEC Filing	May. 10	MT
Resmed Insider Sold Shares Worth $3,178,815, According to a Recent SEC Filing	May. 09	MT
Sector Update: Health Care Stocks Edge Higher Late Afternoon	Apr. 26	MT
Top Midday Gainers	Apr. 26	MT
Sector Update: Health Care Stocks Higher in Afternoon Trading	Apr. 26	MT
In-Line Inflation Data, Tech Earnings Lift US Equity Indexes	Apr. 26	MT
Sector Update: Health Care	Apr. 26	MT
KeyBanc Adjusts Price Target on ResMed to $238 From $227	Apr. 26	MT
ResMed's Fiscal Q3 Non-GAAP Earnings, Revenue Increase; Shares Up Over 17%	Apr. 26	MT
Jefferies Adjusts Price Target on ResMed to $180 From $164	Apr. 26	MT
Oppenheimer Adjusts ResMed Price Target to $200 From $205, Maintains Outperform Rating	Apr. 26	MT
JPMorgan Adjusts Price Target on ResMed to $225 From $198	Apr. 26	MT
Mizuho Adjusts Price Target on ResMed to $220 From $215	Apr. 26	MT
Needham Adjusts Price Target on ResMed to $236 From $224	Apr. 26	MT
Morgan Stanley Adjusts Price Target on ResMed to $219 From $207	Apr. 26	MT
RBC Adjusts Price Target on ResMed to $200 From $187	Apr. 26	MT
ResMed Declares Quarterly Dividend as Fiscal Q3 Profit Jumps 29%; Shares Up 7%	Apr. 25	MT
ResMed tops quarterly profit estimates on strong demand for sleep apnea devices	Apr. 25	RE

ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (50.4%); - masks (37.9%); - software as a service (11.7%). At the end of June 2021, the group had 6 production sites located in the United States (2), Australia, China, Singapore and Malaysia. The United States accounts for 61.4% of net sales.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-07-31 - Q4 2024 Earnings Release (Projected)

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

ResMed, Inc. continues to make headway in the sleep market

December 11, 2023 at 05:55 am EST

More Strategies

Ratings for ResMed, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

189.4 USD

Average target price

220.4 USD

Spread / Average Target

+16.41%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
RESMED, INC.	+10.07%	27.46B
THERMO FISHER SCIENTIFIC	+0.59%	207B
DANAHER CORPORATION	+3.92%	181B
INTUITIVE SURGICAL, INC.	+30.07%	155B
BOSTON SCIENTIFIC CORPORATION	+32.42%	112B
SIEMENS HEALTHINEERS AG	+1.98%	64.42B
EDWARDS LIFESCIENCES CORPORATION	+19.65%	54.38B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-1.86%	47.43B
AGILENT TECHNOLOGIES, INC.	-9.53%	37.17B
GE HEALTHCARE TECHNOLOGIES INC.	-1.28%	34.81B

Other Advanced Medical Equipment & Technology

ResMed, Inc.

Equities

RMD

US7611521078

Advanced Medical Equipment & Technology

ResMed Inc. Announces Ordinary Distribution for the Quarter Ended December 31, 2021, Payable on March 17, 2022

Latest news about ResMed, Inc.

Chart ResMed, Inc.

Company Profile

Income Statement Evolution

Analysis / Opinion

Ratings for ResMed, Inc.

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Advanced Medical Equipment & Technology